Innova Pharmactive Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 1.53 Cr
as on 14-12-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.20 Cr
as on 14-12-2024
- Satisfied Charges ₹ 2.10 Cr
as on 14-12-2024
- Revenue -25.47%
(FY 2022)
- Profit -33.54%
(FY 2022)
- Ebitda -17.17%
(FY 2022)
- Net Worth 13.11%
(FY 2022)
- Total Assets -3.81%
(FY 2022)
About Innova Pharmactive
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.53 Cr.
The company currently has active open charges totaling ₹4.20 Cr. The company has closed loans amounting to ₹2.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amit Khandelwal, Rakesh Khandelwal, Sulabh Khandelwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100MH2010PTC204654
- Company No.
204654
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Innova Pharmactive?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Khandelwal  | Whole-Time Director | 22-Jun-2010 | Current |
| Amit Khandelwal | Whole-Time Director | 22-Jun-2010 | Current |
| Sulabh Khandelwal | Whole-Time Director | 29-Jun-2012 | Current |
| Umang Khandelwal | Whole-Time Director | 03-Sep-2022 | Current |
Financial Performance of Innova Pharmactive.
Innova Pharmactive Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 25.47% decrease. The company also saw a substantial fall in profitability, with a 33.54% decrease in profit. The company's net worth Soared by an impressive increase of 13.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innova Pharmactive?
Unlock access to Innova Pharmactive's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Innova Remedies Private LimitedActive 25 years 6 monthsAmit Khandelwal, Rakesh Khandelwal and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 20 Jul 2023 | ₹6.00 M | Open |
Others Creation Date: 23 Oct 2013 | ₹1.80 Cr | Open |
Others Creation Date: 10 Oct 2011 | ₹1.80 Cr | Open |
How Many Employees Work at Innova Pharmactive?
Innova Pharmactive has a workforce of 24 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innova Pharmactive, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innova Pharmactive's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
